PTC Therapeutics, Inc. (PTCT) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$63.16
Day's range
$69.17

PTC Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 05/13/2026 12.95 M $882.20 M   1.33% 15.69%
RTW INVESTMENTS, LP 05/15/2026 7.75 M $527.76 M   0.00% 9.39%
JANUS HENDERSON GROUP PLC 05/18/2026 7.19 M $490.00 M   48.28% 8.72%
05/08/2026 4.80 M $327.34 M   100.00% 5.82%
STATE STREET CORP 05/15/2026 4.35 M $296.13 M   3.34% 5.27%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 3.94 M $268.61 M   1.95% 4.78%
VANGUARD CAPITAL MANAGEMENT LLC 05/15/2026 3.68 M $250.46 M   100.00% 4.45%
TORONTO DOMINION BANK 05/15/2026 3.03 M $206.16 M   -26.88% 3.67%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 2.21 M $150.59 M   9.62% 2.68%
ARMISTICE CAPITAL, LLC 05/15/2026 2.07 M $141.33 M   -25.96% 2.51%
BANK OF AMERICA CORP /DE/ 05/18/2026 1.89 M $128.55 M   31.80% 2.29%
HOOD RIVER CAPITAL MANAGEMENT LLC 05/15/2026 1.66 M $113.41 M   65.95% 2.02%
D. E. SHAW & CO., INC. 05/15/2026 1.64 M $111.76 M   -5.99% 1.99%
FMR LLC 05/15/2026 1.53 M $104.13 M   -9.09% 1.85%
TANG CAPITAL MANAGEMENT LLC 05/15/2026 1.50 M $102.20 M   0.00% 1.82%
UBS GROUP AG 05/05/2026 1.36 M $92.98 M   41.48% 1.65%
JEFFERIES FINANCIAL GROUP INC. 05/08/2026 1.35 M $92.28 M   -18.33% 1.64%
PICTET ASSET MANAGEMENT HOLDING SA 04/22/2026 1.18 M $80.06 M   20.92% 1.43%
FRANKLIN RESOURCES INC 05/13/2026 1.12 M $76.40 M   -12.85% 1.36%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2026 1.02 M $69.20 M   -10.60% 1.23%
PALO ALTO INVESTORS LP 05/15/2026 921.61 K $62.79 M   1.96% 1.12%
BNP PARIBAS ARBITRAGE, SNC 05/12/2026 920.48 K $62.71 M   11.08% 1.12%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 890.72 K $60.67 M   42.04% 1.08%
SG AMERICAS SECURITIES, LLC 04/16/2026 879.70 K $59.93 M   -1.65% 1.07%
INVESCO LTD. 05/12/2026 865.45 K $58.96 M   99.28% 1.05%
GOLDMAN SACHS GROUP INC 05/15/2026 827.63 K $56.39 M   -19.10% 1.00%
NORTHERN TRUST CORP 05/14/2026 806.28 K $54.93 M   4.79% 0.98%
WOODLINE PARTNERS LP 05/15/2026 744.99 K $50.76 M   30.34% 0.90%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 731.64 K $49.85 M   -0.45% 0.89%
JUPITER ASSET MANAGEMENT LTD 05/12/2026 711.46 K $48.47 M   96.99% 0.86%
MORGAN STANLEY 05/15/2026 674.13 K $45.93 M   -25.53% 0.82%
NUVEEN, LLC 04/30/2026 667.02 K $45.44 M   -4.60% 0.81%
BOSTON PARTNERS 05/11/2026 647.48 K $44.11 M   32.69% 0.78%
LORD, ABBETT & CO. LLC 05/14/2026 617.12 K $42.04 M   -1.59% 0.75%
ENSIGN PEAK ADVISORS, INC 05/13/2026 582.32 K $39.67 M   107.55% 0.71%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 553.66 K $37.72 M   100.00% 0.67%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 533.30 K $36.33 M   -12.23% 0.65%
BANK OF NEW YORK MELLON CORP 05/05/2026 522.76 K $35.62 M   1.57% 0.63%
PRINCIPAL FINANCIAL GROUP INC 05/04/2026 515.00 K $35.09 M   7.54% 0.62%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 513.82 K $35.01 M   100.00% 0.62%
LOOMIS SAYLES & CO L P 05/14/2026 493.60 K $33.63 M   100.00% 0.60%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 475.15 K $32.37 M   3.27% 0.58%
MARSHALL WACE, LLP 05/15/2026 460.64 K $31.38 M   85.93% 0.56%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2026 460.56 K $31.38 M   100.00% 0.56%
PARKMAN HEALTHCARE PARTNERS LLC 05/15/2026 431.36 K $29.39 M   169.30% 0.52%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 05/15/2026 425.24 K $28.97 M   -0.30% 0.52%
ARMISTICE CAPITAL, LLC 05/15/2026 390.00 K $26.57 M   100.00% 0.47%
CITADEL ADVISORS LLC 05/15/2026 385.20 K $26.24 M   -66.63% 0.47%
ROCKEFELLER CAPITAL MANAGEMENT L.P. 05/14/2026 384.67 K $26.21 M   -5.14% 0.47%
06/12/2026 376.17 K $25.63 M   100.00% 0.46%

PTC Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 505 institutional investors and hedge funds held shares of PTC Therapeutics Inc. The most heavily invested institutionals were:

Pictet Asset Management Holding SA: 1.15 M

Boston Partners: 718,574

Bank of New York Mellon Corp: 553,462

PRINCIPAL FINANCIAL GROUP INC: 541,635

Russell Investments Group, Ltd.: 418,025

Universal- Beteiligungs- und Servicegesellschaft mbH: 135,633

118.35% of PTC Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 115.08 M shares in the last 24 months. This purchase volume represents approximately $7.87 B in transactions.